Minoxidil ABECE
Topical solution for hereditary hair loss (androgenetic alopecia)
Minoxidil ABECE is a topical solution containing the active substance minoxidil, which stimulates hair growth. It is used to treat early and moderate forms of hereditary hair loss (androgenetic alopecia) in men and women over 18 years of age. Available over the counter in 20 mg/ml and 50 mg/ml strengths, minoxidil is one of the most extensively studied and widely used treatments for pattern hair loss worldwide.
Quick Facts
Key Takeaways
- Minoxidil is a topical solution applied directly to the scalp twice daily to stimulate hair growth in hereditary hair loss (androgenetic alopecia).
- Approximately 4 out of 5 men and 3 out of 5 women experience some degree of reduced hair loss or hair regrowth with regular use.
- Results typically become visible after 2–4 months of continuous use; treatment must be maintained long-term to preserve benefits.
- The most common side effects are temporary scalp irritation and an initial increase in hair shedding during the first 2–6 weeks.
- Minoxidil is available over the counter and should not be used by individuals under 18, pregnant or breastfeeding women, or those with heart conditions without consulting a physician.
What Is Minoxidil ABECE and What Is It Used For?
Quick Answer: Minoxidil ABECE is a topical solution containing minoxidil that stimulates hair follicle growth. It is used to treat early and moderate hereditary hair loss (androgenetic alopecia) in adults over 18 years of age.
Minoxidil ABECE contains the active substance minoxidil, a vasodilator that was originally developed as an oral medication for high blood pressure. During clinical trials in the 1970s, researchers observed an unexpected side effect: significant hair growth in patients taking the drug. This discovery led to the development of topical minoxidil formulations specifically designed to treat hair loss, which have since become one of the most widely used hair loss treatments globally.
The exact mechanism by which minoxidil promotes hair growth is not fully understood. Current research suggests it works through several pathways: it opens potassium channels in vascular smooth muscle, which increases blood flow to hair follicles; it stimulates the production of vascular endothelial growth factor (VEGF), promoting new blood vessel formation around follicles; and it extends the anagen (active growth) phase of the hair cycle while shortening the telogen (resting) phase. The net result is that miniaturized hair follicles are revitalized, producing thicker, longer hairs.
Use in Men
In men, Minoxidil ABECE is indicated for treating hair loss or thinning at the crown (vertex) of the head. Younger men who have experienced hair loss for a shorter duration or who have smaller areas of thinning tend to respond best to treatment. Men with extensive bald areas that have been present for many years are less likely to achieve significant regrowth, though some benefit may still occur. Clinical studies show that approximately 4 out of 5 men experience a slowing of hair loss, and the majority of users see some degree of new hair growth. The 5% (50 mg/ml) concentration is commonly recommended for men.
Use in Women
In women, Minoxidil ABECE is used to treat diffuse thinning at the crown of the head, which is the typical pattern of female androgenetic alopecia. Approximately 3 out of 5 women experience varying degrees of new hair growth with regular use. Women typically present with diffuse thinning rather than the receding hairline pattern seen in men. The 2% (20 mg/ml) concentration is generally recommended for women, as higher concentrations may increase the risk of unwanted facial hair growth.
Minoxidil is also marketed under several other brand names, including Minoxidil ABECE Forte, Minoxidil Apofri, Minoxidil Apofri Forte, Minoxidil NET Forte, Minoxidil Orifarm, Minoxidil Orifarm Forte, and Rogaine forte. All contain the same active ingredient and work through the same mechanism.
What Should You Know Before Using Minoxidil ABECE?
Quick Answer: Do not use minoxidil if you are allergic to it, have heart disease, or are pregnant/breastfeeding. Consult a physician if you have cardiovascular conditions before starting treatment.
Contraindications
Do not use Minoxidil ABECE if you are allergic (hypersensitive) to minoxidil or to any of the other ingredients in the product (propylene glycol, ethanol, or purified water). Signs of an allergic reaction may include rash, itching, swelling, or difficulty breathing.
- Your hair loss pattern does not involve thinning at the crown of the head
- No one else in your family has experienced hair loss (hair loss may not be androgenetic)
- Your hair loss is sudden, patchy, or of unknown origin
- You do not know the cause of your hair loss
- Your scalp is red, inflamed, irritated, infected, or painful
- Your hair loss began after childbirth
- You are under 18 years of age
Warnings and Precautions
Talk to your doctor, pharmacist, or nurse before using Minoxidil ABECE if you have any heart condition, including abnormal heart rhythm or heart rate, angina (chest pain), or circulatory disorders. Minoxidil was originally developed as a blood pressure medication, and although topical absorption is minimal, individuals with cardiovascular conditions should exercise caution.
Minoxidil ABECE should not be used if hair loss occurs suddenly, in patches, or if the scalp shows signs of redness, inflammation, irritation, infection, or tenderness. These symptoms may indicate a different type of hair loss that requires medical evaluation before treatment.
- Chest pain
- Rapid heart rate (tachycardia)
- Dizziness or fainting
- Sudden, unexplained weight gain
- Swelling of hands or feet (edema)
- Persistent redness or irritation of the treated scalp areas
- Swelling of the face, tongue, or throat
- Difficulty swallowing
- Hives or breathing difficulties (signs of severe allergic reaction)
Avoid contact with eyes, mouth, and other mucous membranes, as well as broken skin. If accidental contact occurs, rinse thoroughly with cold water. Since the solution contains ethanol (alcohol), it is highly flammable — keep away from heat sources, sparks, and open flames.
Using more than the recommended dose or applying more frequently will not improve results and may increase the risk of side effects. Continued use is necessary to increase and maintain hair regrowth; if treatment is discontinued, hair loss will resume.
During the first 2–6 weeks of treatment, a temporary increase in hair shedding may occur. This happens because dormant hair follicles transition to the active growth phase, pushing out old resting hairs. If increased shedding continues for more than two weeks, discontinue treatment and consult a doctor.
Safety Around Children
Accidental ingestion of minoxidil can cause serious cardiovascular side effects. Keep this product out of the reach and sight of children at all times. Cases of excessive hair growth on infants' bodies have been reported following skin contact with areas where caregivers had applied topical minoxidil. The hair growth returned to normal within months after contact was eliminated. Take precautions to ensure children do not come into contact with areas of your body where minoxidil has been applied. Consult a physician if you notice excessive hair growth on your child's body while you are using topical minoxidil.
Minoxidil ABECE is not recommended for children and adolescents under 18 years of age, as safety and efficacy data are not available for this age group.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before using this medicine.
Pregnancy: The safety of topical minoxidil during pregnancy has not been established. Oral minoxidil has been associated with fetal toxicity in animal studies. Minoxidil ABECE must not be used during pregnancy.
Breastfeeding: Minoxidil is excreted in breast milk. A breastfed infant could potentially be affected. Minoxidil ABECE must not be used during breastfeeding.
Driving and Operating Machinery
Minoxidil ABECE may cause dizziness or low blood pressure in some individuals. If you experience these side effects, do not drive or operate machinery. You are responsible for assessing whether you are fit to drive or perform tasks requiring alertness.
How Does Minoxidil ABECE Interact with Other Drugs?
Quick Answer: Minoxidil ABECE should not be used simultaneously with other topical scalp medications. Certain topical drugs like tretinoin, dithranol, and corticosteroids may alter minoxidil absorption through the skin.
Drug interactions with topical minoxidil are relatively limited compared to oral medications, primarily because systemic absorption from topical application is low. However, interactions can occur when other substances are applied to the same area of skin, altering the rate or extent of minoxidil absorption. Always inform your doctor or pharmacist about all medications you are using, including prescription drugs, over-the-counter products, and herbal supplements.
Topical Drug Interactions
Minoxidil ABECE should not be used at the same time as other topical medications applied to the scalp. The following substances may interact with minoxidil when applied to the same skin area:
| Interacting Drug | Type | Effect | Clinical Significance |
|---|---|---|---|
| Tretinoin (retinoic acid) | Topical retinoid | Increases skin permeability, leading to enhanced minoxidil absorption | Moderate — may increase systemic side effects |
| Dithranol (anthralin) | Topical anti-psoriatic | May alter minoxidil absorption through the skin | Moderate — unpredictable absorption changes |
| Betamethasone | Topical corticosteroid | May increase or decrease minoxidil absorption | Moderate — altered treatment efficacy |
| Other topical scalp treatments | Various | May interact with minoxidil or its vehicle ingredients | Variable — consult pharmacist |
Considerations with Systemic Medications
Although topical minoxidil has limited systemic absorption, patients taking oral antihypertensive medications should be aware that additive blood pressure-lowering effects are theoretically possible, particularly if minoxidil is applied to areas with compromised skin barrier or over excessively large surface areas. If you are taking blood pressure medications, inform your physician before starting topical minoxidil treatment.
Minoxidil ABECE contains propylene glycol and ethanol as excipients. These ingredients may interact with other topical formulations, potentially altering the absorption characteristics of co-applied medications. As a general rule, allow Minoxidil ABECE to dry completely before applying any other scalp products.
What Is the Correct Dosage of Minoxidil ABECE?
Quick Answer: Apply 1 ml (6 spray pumps) to the affected scalp area twice daily, morning and evening. Hair and scalp must be completely dry before application. Do not exceed 2 ml per day.
Always use Minoxidil ABECE exactly as described in the patient information leaflet or as directed by your doctor, pharmacist, or nurse. The standard dosing regimen is consistent regardless of concentration (2% or 5%), though your healthcare provider may recommend a specific concentration based on your sex and severity of hair loss.
Adults (Over 18 Years)
Standard Dosing
- Dose: 1 ml per application (equivalent to 6 spray pumps)
- Frequency: Twice daily (morning and evening)
- Maximum daily dose: 2 ml per day
- Application area: Directly onto the area(s) of hair loss on the scalp
- Duration: Continuous use required; minimum 2–4 months before visible results
Application Instructions
- Prepare: Ensure hair and scalp are completely dry before application.
- First use: Remove the bottle cap, attach the spray pump securely, and press the nozzle several times until an even spray is produced.
- Apply: Distribute 6 spray pumps (1 ml) over the areas of hair loss. Target the solution directly onto the scalp, not onto the hair.
- Massage: Gently spread and massage the solution into the scalp using your fingertips.
- Wash hands: Wash hands thoroughly after each application to prevent unwanted hair growth on other body areas.
- Allow to dry: Let the solution dry completely before going to bed or applying any hair styling products.
Use a silicone-free shampoo (also labeled as dimethicone-free) when washing your hair, as silicone can reduce the effectiveness of minoxidil by creating a barrier on the scalp.
Children and Adolescents
Minoxidil ABECE is not recommended for use in individuals under 18 years of age. Safety and efficacy data are not available for this age group. If a child or adolescent is experiencing hair loss, a physician should evaluate the underlying cause before any treatment is considered.
Elderly Patients
No specific dose adjustment is required for elderly patients. However, older adults may have a higher prevalence of cardiovascular conditions that warrant additional caution. Consult a physician before starting treatment if you have any heart or circulatory problems.
Treatment Duration
Hair growth is a slow process, and minoxidil requires time to produce visible effects. Continuous twice-daily use for a minimum of 2–4 months is typically necessary before results become noticeable. In some cases, it may take longer. If no improvement is observed after 4 months of consistent use, treatment should be discontinued. Discuss with your doctor if symptoms do not improve within this timeframe.
Once beneficial effects are achieved, continuous use is essential to maintain hair regrowth. Discontinuation of treatment will result in a gradual return of hair loss over the following 3–4 months.
Missed Dose
If you forget to apply a dose, do not apply a double dose to make up for the missed one. Simply resume your regular application schedule as described above. Occasional missed doses are unlikely to significantly affect long-term results, but consistent daily use provides the best outcomes.
Overdose
If you accidentally use too much Minoxidil ABECE, or if a child accidentally ingests the product, contact a doctor, hospital emergency department, or poison control center immediately for risk assessment and advice.
- Rapid heart rate (tachycardia)
- Low blood pressure (hypotension)
- Unusual tiredness or fatigue
- Dizziness or lightheadedness
- Fluid retention (swelling)
These effects are most likely to occur from accidental oral ingestion rather than topical over-application. However, applying more than the recommended amount or applying to broken skin can increase systemic absorption.
What Are the Side Effects of Minoxidil ABECE?
Quick Answer: The most common side effect is headache. Scalp irritation, unwanted hair growth, and temporary increased hair shedding are also commonly reported. Serious side effects such as chest pain or rapid heartbeat are rare.
Like all medicines, Minoxidil ABECE can cause side effects, although not everybody gets them. Most side effects are mild and relate to local skin reactions caused by the alcohol (ethanol) and propylene glycol in the solution. These local effects are usually temporary and often resolve as the scalp adjusts to the treatment.
During the first 2–6 weeks of treatment, a temporary increase in hair shedding is common. This occurs because dormant hair follicles transition from a resting phase (telogen) to an active growth phase (anagen). Old resting hairs are pushed out as new hairs begin growing. If shedding continues for more than 2 weeks, discontinue treatment and consult your doctor.
- Swelling of the face, lips, or throat; difficulty swallowing; hives or breathing difficulties (signs of a serious allergic reaction)
- Heart palpitations, dizziness, or fainting episodes
- Chest pain
Very Common
Affects more than 1 in 10 users
- Headache
Common
Affects up to 1 in 10 users
- Scalp irritation (redness, itching, dryness) — usually caused by the alcohol and propylene glycol excipients
- Skin inflammation (dermatitis)
- Itching (pruritus)
- Rash
- Unwanted hair growth (hypertrichosis) on areas other than the scalp
- Shortness of breath (dyspnea)
- Swollen hands and feet (peripheral edema)
- Weight gain
Uncommon
Affects up to 1 in 100 users
- Dizziness
- Nausea
Rare
Affects up to 1 in 1,000 users
- Heart palpitations
- Increased heart rate (tachycardia)
- Chest pain
- Folliculitis (inflammation of hair follicles)
Not Known
Frequency cannot be estimated from available data
- Low blood pressure (hypotension)
- Hypersensitivity reactions
- Allergic contact dermatitis
- Eye irritation
- Vomiting
- Application site reactions: itching, irritation, pain, rash, swelling, dry skin, redness of scalp, ears, or face
- More severe skin reactions: peeling, inflammation, blistering, bleeding, or ulceration at the application site
- Temporary hair loss (telogen effluvium)
- Changes in hair color or texture
If you experience persistent or bothersome local irritation, it may be due to the propylene glycol or ethanol in the solution rather than the minoxidil itself. Some formulations are available without propylene glycol, which may be better tolerated. Consult your pharmacist about alternative formulations if irritation is a concern.
Reporting Side Effects
Reporting suspected side effects after a medicine has been authorized is important. It allows continuous monitoring of the medicine's benefit-risk balance. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority.
How Should You Store Minoxidil ABECE?
Quick Answer: Store below 30°C in a tightly closed container, away from heat and open flames. Keep out of the reach and sight of children. Highly flammable.
Proper storage of Minoxidil ABECE is essential to maintain the product's effectiveness and safety. The solution contains ethanol (alcohol), which makes it highly flammable, so special precautions regarding heat and flame exposure are necessary.
- Temperature: Store at or below 30°C (86°F). Do not freeze.
- Container: Keep the bottle tightly closed when not in use.
- Fire safety: The solution is highly flammable. Do not expose to heat, hot surfaces, sparks, open flames, or other ignition sources. Do not smoke near the product.
- Children: Keep out of the sight and reach of children. Accidental ingestion can cause serious cardiovascular side effects.
- Expiry: Do not use after the expiry date printed on the packaging. The expiry date refers to the last day of the stated month.
- Disposal: Do not dispose of medicines via wastewater or household waste. Return unused or expired products to a pharmacy for proper disposal to protect the environment.
What Does Minoxidil ABECE Contain?
Quick Answer: The active ingredient is minoxidil (20 mg/ml or 50 mg/ml). Inactive ingredients include propylene glycol, ethanol (alcohol), and purified water.
Active Ingredient
The active substance is minoxidil. Minoxidil ABECE is available in two strengths:
- 20 mg/ml (2%): Each milliliter contains 20 mg of minoxidil
- 50 mg/ml (5%): Each milliliter contains 50 mg of minoxidil (marketed as Minoxidil ABECE Forte)
Inactive Ingredients (Excipients)
The other ingredients are:
- Propylene glycol (150 mg per ml) — acts as a solvent and skin penetration enhancer. May cause skin irritation in some individuals.
- Ethanol (alcohol) (0.6 ml per ml) — acts as a solvent. May cause a burning sensation on damaged skin. Makes the product highly flammable.
- Purified water — used as a diluent.
Appearance and Packaging
Minoxidil ABECE is a clear, colorless to slightly yellowish solution supplied in plastic bottles. A spray pump with an extended spray head is included with each package. Available pack sizes include 60 ml, 2 × 60 ml, and 3 × 60 ml. Not all pack sizes may be marketed in every country.
Frequently Asked Questions About Minoxidil ABECE
Minoxidil typically requires at least 2 to 4 months of continuous twice-daily use before visible results appear. In some cases, it may take up to 6 months. During the first 2–6 weeks, you may notice a temporary increase in hair shedding. This is normal and indicates that new hairs are pushing out old resting hairs. If no improvement is seen after 4 months of consistent use, treatment should generally be discontinued, and you should consult your doctor.
If you discontinue minoxidil, the beneficial effects will gradually reverse within 3 to 4 months. Hair that was regrown or maintained through treatment will fall out, and hair loss will continue at its natural rate. Minoxidil does not cure androgenetic alopecia — it manages the condition and requires ongoing use to maintain results. There is no rebound effect; hair loss simply resumes at the rate it would have progressed without treatment.
Yes, minoxidil is approved for women over 18 with hereditary hair loss (androgenetic alopecia), specifically thinning at the crown. The 2% (20 mg/ml) concentration is generally recommended for women. About 3 out of 5 women experience some degree of hair regrowth. Women who are pregnant, planning to become pregnant, or breastfeeding must not use minoxidil. Women experiencing hair loss should consult a physician to rule out other causes such as thyroid disorders, iron deficiency, or hormonal imbalances.
Clinical studies and decades of post-marketing surveillance have shown that topical minoxidil is generally safe for long-term use when applied as directed. The most common long-term concern is local skin irritation, which can usually be managed by switching to propylene glycol-free formulations. Serious systemic side effects are very rare with topical application. It is advisable to have periodic check-ups with your healthcare provider during long-term treatment, especially if you develop new symptoms.
No. Minoxidil is specifically indicated for androgenetic alopecia (hereditary pattern hair loss) with thinning at the crown. It is not proven effective for hair loss caused by other conditions such as alopecia areata (autoimmune patchy hair loss), telogen effluvium (stress-related shedding), chemotherapy-induced alopecia, traction alopecia, or scarring alopecia. If you are unsure about the cause of your hair loss, consult a dermatologist for proper diagnosis before starting treatment.
You should not apply other topical medications to the scalp while using minoxidil. However, regular hair styling products (gels, sprays, etc.) can be used after the minoxidil solution has dried completely. Use silicone-free (dimethicone-free) shampoo, as silicone can create a barrier that reduces minoxidil absorption. Avoid inhaling the sprayed solution during application. If you need to use prescription scalp treatments, consult your doctor about the appropriate timing and whether concurrent use is safe.
References
- Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002;47(3):377-385. doi:10.1067/mjd.2002.124088
- Lucky AW, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology. 2004;50(4):541-553. doi:10.1016/j.jaad.2003.06.014
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186-194. doi:10.1111/j.1365-2133.2004.05785.x
- European Medicines Agency (EMA). Minoxidil — Summary of Product Characteristics. Available at: www.ema.europa.eu
- U.S. Food and Drug Administration (FDA). Minoxidil Topical Solution — Drug Label Information. DailyMed. National Library of Medicine. Available at: dailymed.nlm.nih.gov
- Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. American Journal of Clinical Dermatology. 2014;15(3):217-230. doi:10.1007/s40257-014-0077-5
- Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal of the German Society of Dermatology. 2011;9(Suppl 6):S1-S57. doi:10.1111/j.1610-0379.2011.07802.x
- World Health Organization (WHO). WHO Model List of Essential Medicines — 23rd List, 2023. Geneva: WHO; 2023.
- British National Formulary (BNF). Minoxidil — Dermatological preparations. Available at: bnf.nice.org.uk
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy. 2019;13:2777-2786. doi:10.2147/DDDT.S214907
Editorial Team
Medical Content Team
Dermatology & Pharmacology Specialists
Board-certified physicians with expertise in dermatological treatments and clinical pharmacology. All content follows GRADE evidence framework and international guidelines.
Medical Review Board
Independent Expert Panel
Independent panel reviewing all pharmaceutical content for accuracy, completeness, and adherence to current evidence-based guidelines from EMA, FDA, and WHO.
This article was written by the iMedic Medical Content Team and independently reviewed by the iMedic Medical Review Board. Last medical review: . Content is based on peer-reviewed research and international pharmaceutical guidelines. iMedic receives no funding from pharmaceutical companies.